E Fund Management Co., Ltd. Travere Therapeutics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.8 Billion
- Q2 2024
A detailed history of E Fund Management Co., Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 11,071 shares of TVTX stock, worth $153,554. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,071
Previous 28,128
60.64%
Holding current value
$153,554
Previous $216,000
57.87%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$106 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$104 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$102 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$91.8 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$62.2 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $890M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...